Peripheral Nerve Cell Differentiation Using High-Density Neural Progenitors
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for producing peripheral nerve cells from undifferentiated cells, such as induced pluripotent stem cells, result in low purity and inefficient differentiation, limiting their use in research and regenerative medicine.
Innovation Solution
A method involving adherent culture of undifferentiated cells to induce neural progenitor cells without feeder cells, followed by seeding at a high density to achieve confluent state for further differentiation into peripheral nerve cells, using specific culture conditions and additives.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If embryonic stem cells are used for cell replacement therapy, then the cells can differentiate into various cell types including peripheral nerve cells, but it is difficult to obtain pure peripheral nerve cell populations and the differentiation process lacks control
Solution Approach 1:
The patent segments the undifferentiated embryonic stem cell population into specific differentiated lineages by introducing distinct small molecule compounds. Each compound guides differentiation toward particular cell types (e.g., peripheral nerve cells, motor neurons, interneurons), thereby segmenting the versatile differentiation capability into controlled, pure populations of specific cell types.
Solution Approach 2:
The patent changes the chemical parameters of the differentiation environment by introducing specific small molecule compounds (e.g., compounds 1-6). These parameter changes in the molecular environment trigger and control the differentiation process, enabling precise control over cell fate and achieving high purity peripheral nerve cell populations while maintaining adaptability.
2Duration of action of stationary object
If conventional cell culture methods are used, then the cells can be maintained in culture, but the cells undergo spontaneous differentiation into multiple cell types making it difficult to obtain pure populations
Solution Approach 1:
The patent introduces small molecule compounds as intermediary substances that mediate between the culture conditions and the cell differentiation process. These compounds act as chemical mediators that block spontaneous differentiation pathways and guide cells toward specific lineages, maintaining culture viability while ensuring population homogeneity.
Solution Approach 2:
The patent modifies the cultural parameters by adding specific small molecule compounds to the culture medium. This parameter change transforms the spontaneous differentiation process into a controlled differentiation process, allowing long-term culture maintenance while achieving homogeneous cell populations through chemical control of differentiation timing and direction.
3Adaptability or versatility
If embryonic stem cells are differentiated without controlled methods, then various cell types can be generated, but the process is time-consuming and yields mixed cell populations
Solution Approach 1:
The patent applies preliminary action by pre-treating embryonic stem cells with specific small molecule compounds before initiating differentiation. This preliminary chemical treatment primes the cells and accelerates the differentiation process, reducing the time required while maintaining the ability to generate diverse cell types with high purity.
Solution Approach 2:
The patent changes the temporal parameters of differentiation by introducing small molecule compounds that accelerate the differentiation process. These compounds modify the kinetic parameters of cell fate determination, enabling faster generation of pure cell populations without sacrificing adaptability to produce various cell types.
4Adaptability or versatility
If undifferentiated embryonic stem cells are used for transplantation, then the cells have full differentiation potential, but they may form teratomas and cause immune rejection
Solution Approach 1:
The patent extracts the harmful undifferentiated state from the stem cells by inducing differentiation into specific cell types using small molecule compounds. This extraction of the undifferentiated state eliminates the teratoma-forming potential while preserving the beneficial differentiation capacity, producing pure populations of specific cell types suitable for transplantation.
Solution Approach 2:
The patent changes the differentiation state parameter of the stem cells through chemical induction. By modifying the cellular state from undifferentiated to differentiated using small molecule compounds, the patent eliminates harmful properties (teratoma formation, immune rejection) while maintaining useful properties (differentiation potential into therapeutic cell types).
Data Source
Figure 1
Figure 2
Figure 3~4
AI summary
Provided is a method for efficiently manufacturing high-purity peripheral nerve cells from undifferentiated cells. The method for manufacturing peripheral nerve cells from undifferentiated cells having an ability to differentiate into peripheral nerve cells includes the following steps (a) and (b): (a) culturing undifferentiated cells having an ability to differentiate into peripheral nerve cells to induce differentiation into neural progenitor cells without detaching a grown colony from a culture vessel; and (b) detaching the neural progenitor cells produced in the step (a) from the culture vessel, then seeding the cells at a seeding density of 2×105 to 6×105 cells/cm2 to a culture vessel, and culturing the cells for 14 to 42 days.